Clinical Study
Blood Monocyte Phenotype Fingerprint of Stable Coronary Artery Disease: A Cross-Sectional Substudy of SMARTool Clinical Trial
Figure 2
Cumulative graphic representation () of IL-10 plasma levels (pg/ml) [(a); ANOVA ] and IFN-γ/IL-10 ratio [(b); ANOVA ] in the three CAD severity groups. CAD1: no CAD/minimal CAD; CAD2: non-obstructive CAD; CAD3: obstructive CAD.
(a) |
(b) |